Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. (MRSN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MRSN · as of Jun 9, 2026
Key Statistics
Explore Mersana Therapeutics, Inc. Data
mrsn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 19 · Buy rate: 57.9%
The MRSN analyst consensus is Buy, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month price target is $10.00, representing -65.61% downside from the current price of $29.08.
Competitors & Peers
mrsn competitorsMRSN
ALGS
BCAB
BRNS
FGEN
INMBStock Performance
Full HistoryAbout Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering novel antibody-drug conjugates (ADCs) for cancer patients with pressing unmet medical needs. Their flag…
what is mersana therapeutics, inc. · mrsn stock overview · mersana therapeutics, inc. company profile · who is mersana therapeutics, inc. ceo · mrsn NASDAQ · mersana therapeutics, inc. headquarters · mersana therapeutics, inc. business segments
About Stock Overview & Key Data
Mersana Therapeutics, Inc. (MRSN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 28, 2017. As of the latest trading session, MRSN stock price is $29.08, with a market capitalization of $145.4M. The stock has returned +62.01% over the past 12 months and +0.14% year-to-date.
According to 19 Wall Street analysts, the consensus rating for Mersana Therapeutics, Inc. stock is Buy, with an average 12-month price target of $10.00. In fiscal year 2024, Mersana Therapeutics, Inc. reported revenue of $40.5M and net income of -$69.2M. For detailed data — including Mersana Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Mersana Therapeutics, Inc. (MRSN) stock price is $29.08. The stock is traded on NASDAQ under the ticker symbol MRSN. The 52-week range is $5.21 – $30.39.